Singapore markets open in 5 hours 6 minutes
Straits Times Index
3,102.21 -32.66 (-1.04%) S&P 500
3,769.87 -48.96 (-1.28%) Dow
30,669.29 -360.02 (-1.16%) Nasdaq
10,982.63 -195.26 (-1.75%) BTC-USD
18,950.31 -1,176.31 (-5.84%) CMC Crypto 200
406.55 -24.92 (-5.78%)
Orphazyme A/S (ORPHY)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
As of 03:16PM EDT. Market open.
| Previous close | 0.1000 |
| Open | 0.1000 |
| Bid | N/A x N/A |
| Ask | N/A x N/A |
| Day's range | 0.0002 - 0.2000 |
| 52-week range | 0.0002 - 8.1000 |
| Volume | |
| Avg. volume | 120,392 |
| Market cap | 7,062 |
| Beta (5Y monthly) | 1.07 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.5370 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.00 |
- Zacks
KemPharm (KMPH) Stock Up on Deal to Acquire Orphazyme for $12.8M
KemPharm (KMPH) inks deal to acquire Orphazyme A/S, which will add to its portfolio the latter's pipeline candidate, arimoclomol, being developed for treating Niemann-Pick disease type C. Shares rise.
© 2022 Yahoo. All rights reserved.
